We indicate that the network-based on hMENA/Gas6/Axl expression may represent novel prognostic and therapeutic targets and the pattern of hMENA isoform expression in both tumor cells and CAFs may reveal tumor mesenchymal traits identifying cancer subtypes for tailored therapies. The gene discussed is AXL; the disease is neoplasm.